Self-Associating Poly(ethylene oxide)-block-poly(α-carboxyl-ε-caprolactone) Drug Conjugates for the Delivery of STAT3 Inhibitor JSI-124: Potential Application in Cancer Immunotherapy-Reference-Cited by-同舟云学术

Self-Associating Poly(ethylene oxide)-block-poly(α-carboxyl-ε-caprolactone) Drug Conjugates for the Delivery of STAT3 Inhibitor JSI-124: Potential Application in Cancer Immunotherapy

Published:2017-03-09 Issue:8 Volume:14 Page:2570-2584
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Garg Shyam M.¹,Vakili Mohammad Reza¹,Molavi Ommoleila²,Lavasanifar Afsaneh¹³^ORCID

Affiliation:

1. Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta, Canada

2. Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran

3. Department of Chemical and Materials Engineering, Faculty of Engineering, University of Alberta, Edmonton, Alberta, Canada

Funder

Canadian Institutes of Health Research

Alberta Innovates - Health Solutions

Alberta Cancer Foundation

Tata Trusts

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.6b01119

Reference65 articles.

1. The role of STATs in transcriptional control and their impact on cellular function

2. Role of STAT3 in Cancer Metastasis and Translational Advances

3. The role of constitutively activated STAT3 in B16 melanoma cells

4. A Role for STAT3 in Dendritic Cell Regulation by Tumor-Derived Factors

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhancing cancer therapy: The role of drug delivery systems in STAT3 inhibitor efficacy and safety;Life Sciences;2024-06

2. Advances in Polymeric Micelles: Responsive and Targeting Approaches for Cancer Immunotherapy in the Tumor Microenvironment;Pharmaceutics;2023-11-13

3. Targeting the STAT3 oncogenic pathway: Cancer immunotherapy and drug repurposing;Biomedicine & Pharmacotherapy;2023-11

4. Nanomedicine as potential cancer therapy via targeting dysregulated transcription factors;Seminars in Cancer Biology;2023-02

5. Chronobiology and Nanotechnology for Personalized Cancer Therapy;Cancer Nanotechnology;2022-12-14